Federica Cavallo

13.4k total citations · 1 hit paper
256 papers, 9.8k citations indexed

About

Federica Cavallo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Federica Cavallo has authored 256 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Immunology, 87 papers in Oncology and 76 papers in Molecular Biology. Recurrent topics in Federica Cavallo's work include Immunotherapy and Immune Responses (114 papers), Virus-based gene therapy research (40 papers) and Monoclonal and Polyclonal Antibodies Research (36 papers). Federica Cavallo is often cited by papers focused on Immunotherapy and Immune Responses (114 papers), Virus-based gene therapy research (40 papers) and Monoclonal and Polyclonal Antibodies Research (36 papers). Federica Cavallo collaborates with scholars based in Italy, United States and Sweden. Federica Cavallo's co-authors include Guido Forni, Pier‐Luigi Lollini, Piero Musiani, Patrizia Nanni, Elena Quaglino, Laura Conti, Mirella Giovarelli, Carla De Giovanni, Mario P. Colombo and Luisa Lanfrancone and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Federica Cavallo

249 papers receiving 9.6k citations

Hit Papers

A novel transforming protein (SHC) with an SH2 domain is ... 1992 2026 2003 2014 1992 250 500 750 1000

Peers

Federica Cavallo
Olivera J. Finn United States
Keith L. Knutson United States
Michael A. Bookman United States
Donald J. Buchsbaum United States
Ena Wang United States
Lisa H. Butterfield United States
Gerald P. Linette United States
Federica Cavallo
Citations per year, relative to Federica Cavallo Federica Cavallo (= 1×) peers Alexander Eggermont

Countries citing papers authored by Federica Cavallo

Since Specialization
Citations

This map shows the geographic impact of Federica Cavallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Cavallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Cavallo more than expected).

Fields of papers citing papers by Federica Cavallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Cavallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Cavallo. The network helps show where Federica Cavallo may publish in the future.

Co-authorship network of co-authors of Federica Cavallo

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Cavallo. A scholar is included among the top collaborators of Federica Cavallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Cavallo. Federica Cavallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Riccardo, Federica, Laura Conti, Lidia Tarone, et al.. (2024). Cancer vaccines: Target antigens, vaccine platforms and preclinical models. Molecular Aspects of Medicine. 101. 101324–101324. 14 indexed citations
3.
Ruiu, Roberto, et al.. (2023). Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models. Journal of Experimental & Clinical Cancer Research. 42(1). 16 indexed citations
4.
Macagno, Marco, Elisabetta Bolli, Federica Riccardo, et al.. (2022). Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis. Biomedicines. 10(2). 230–230. 1 indexed citations
5.
Seclì, Laura, Lidia Avalle, Laura Conti, et al.. (2021). Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity. Cancer Research. 81(18). 4794–4807. 22 indexed citations
6.
Ruiu, Roberto, Giuseppina Barutello, Maddalena Arigoni, et al.. (2021). Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer. Cancers. 13(4). 894–894. 8 indexed citations
7.
Conti, Laura, et al.. (2021). Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies. Cells. 10(1). 108–108. 19 indexed citations
8.
Anemone, Annasofia, Lorena Consolino, Laura Conti, et al.. (2020). Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential. British Journal of Cancer. 124(1). 207–216. 51 indexed citations
9.
Riccardo, Federica, Giuseppina Barutello, Lidia Tarone, et al.. (2020). Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas. Vaccines. 8(2). 166–166. 5 indexed citations
10.
Ruiu, Roberto, Lidia Tarone, Valeria Rolih, et al.. (2019). Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source. Progress in molecular biology and translational science. 164. 119–188. 39 indexed citations
11.
Witt, Kristina, Maarten A. Ligtenberg, Laura Conti, et al.. (2018). Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma. Cancer Immunology Research. 6(11). 1417–1425. 29 indexed citations
12.
Donofrío, Gaetano, Stefania Lanzardo, Roberto Ruiu, et al.. (2018). Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells. OncoImmunology. 7(12). e1494108–e1494108. 33 indexed citations
13.
Lanzardo, Stefania, Laura Conti, Ronald Rooke, et al.. (2015). Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer. Cancer Research. 76(1). 62–72. 103 indexed citations
14.
Occhipinti, Sergio, Simona Rolla, Cristiana Caorsi, et al.. (2014). Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. Clinical Cancer Research. 20(11). 2910–2921. 26 indexed citations
15.
Riccardo, Federica, Selina Iussich, Lorella Maniscalco, et al.. (2014). CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA. Clinical Cancer Research. 20(14). 3753–3762. 60 indexed citations
16.
Barbieri, Isaia, Sara Pensa, Tania Pannellini, et al.. (2010). Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten. Cancer Research. 70(6). 2558–2567. 124 indexed citations
17.
Sharma, Sanjay, Ana Lucía Dominguez, Soraya Zorro Manrique, et al.. (2008). Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice. Cancer Research. 68(18). 7530–7540. 30 indexed citations
18.
Cavallo, Federica. (2008). Dansero E., Di Meglio G., Donini E., Governa F. (a cura di), Geografia, società, politica. La ricerca in geografia come impegno sociale, Milano, Franco Angeli, 2007. RIVISTA GEOGRAFICA ITALIANA. 115. 107–109.
19.
Capasso, Anna & Federica Cavallo. (2005). L-NAME PREVENTS EEG AND BEHAVIORAL ALTERATIONS INDUCED BY MORPHINE AND DELTORPHIN II IN THE RABBIT.. Biomedical Research-tokyo. 16(1). 368–368. 1 indexed citations
20.
Quaglino, Elena, Simona Rolla, Manuela Iezzi, et al.. (2004). Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. Journal of Clinical Investigation. 113(5). 709–717. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026